Research advances on transgenic plant vaccines

Acta Genetica Sinica

Volumn 33, Issue 4, 2006, Pages 285-293

  Han, Mei ^a   Su, Tao ^a   Zu, Yuan Gang ^a   An, Zhi Gang ^a  

^a NORTHEAST FORESTRY UNIVERSITY   (China)

Author keywords

Biosafety; Plant based vaccines; Recombinant proteins; Transgenic plant vaccines

Indexed keywords

ALGAL PROTEIN; AUTOANTIGEN; CHOLERA TOXIN B SUBUNIT; CHOLERA VACCINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GLYCOPROTEIN GP 120; HEPATITIS B VACCINE; LIPOSOME; MEASLES VACCINE; RABIES VACCINE; RECOMBINANT PROTEIN; RESPIRATORY SYNCYTIAL VIRUS VACCINE; ROTAVIRUS VACCINE; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; TETANUS TOXOID; TRANSACTIVATOR PROTEIN; VACCINE;

BREAST CANCER; CHRONIC DISEASE; CLINICAL TRIAL; CROP PRODUCTION; DRUG DELIVERY SYSTEM; DRUG INHIBITION; DRUG PURIFICATION; DRUG SAFETY; FRUIT GROWTH; HUMAN; INFECTION; LEUKEMIA; LUNG CANCER; MICROCAPSULE; NONHUMAN; PLANT VIRUS; PROTEIN EXPRESSION; REVIEW; TRANSGENIC PLANT; TUBERCULOSIS; VIRAL GENE DELIVERY SYSTEM; VIRUS EXPRESSION;

ALGAE; ANIMALIA; RESPIRATORY SYNCYTIAL VIRUS; ROTAVIRUS;

EID: 33645742380     PISSN: 03794172     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0379-4172(06)60053-X     Document Type: Review

References (77)

1. Raskin I, Ribnicky D M, Komarnytsky S, Ilic N, Poulev A, Borisjuk N, Brinker A, Moreno D A, Ripoll C, Yakoby N, O'Neal J M, Cornwell T, Fridlender P I. Plants and human health in the twenty-first century. Trends in Biotechnol, 2002, 20(12): 522-531.
2. Hiatt A H, Cafferkey R, Bowdish K. Production of antibodies in transgenic plants. Nature, 1989, 342: 76-78.
3. Ko K, Koprowski H. Plant biopharming of monoclonal antibodies. Virus Res, 2005, 111: 93-100.
4. Ma J K C, Drake P M W, Chargelegue D, Obregon P, Prada A. Antibody processing and engineering in plants, and new strategies for vaccine production. Vaccine, 2005, 23: 1814-1818.
5. Mason H S, Arntzen C J. Transgenic plants as vaccine production systems. Tibtech September, 1995, 13: 388-392.
6. Duggan J M, Brooks T J G. A strategic vaccine facility for the UK. Vaccine, 2005, 23: 2090-2094.
7. Peny J M, Gleizes O, Covilard J P. Financial requirements of immunisatin programmes in developing countries: a 2004-2014 perspective. Vaccine, 2005, 23: 4610-4618.
8. Joshi L, Lopez L C. Bioprospecting in plants for engineered proteins. Curr Opin in Plant Biol, 2005, 8: 223-226.
9. Chargelegue D, Obregon P, Drake P M. Transgenic plants for vaccine production, expectations and limitations. Trends Plant Sci, 2001, 6(11): 495-496.
10. Larrick J W, Yu L, Naftzger C, Jaiswal S, Wycoff K. Production of secretory IgA antibodies in plants. Biomol Eng, 2001, 18: 87-94.
11. Daniell H, Kumar S, Dufourmantel N. Breakthrough in chloroplast genetic engineering of agronomically important crops. Trends Biotechnol, 2005, 23(5): 238-245.
12. Fischer R, Stoger E, Schillberg S, Christou P, Twyman R M. Plant-based production of biopharmaceuticals. Curr Opin Plant Biol, 2004, 7(2): 152-158.
13. Twyman R M, Stoger E, Schillberg S, Christou P, Fischer R. Molecular farming in plants: host systems and expression technology. Trends Biotechnol, 2003, 21: 570-578.
14. Walmsley A M, Arntzen C J. Plants for delivery of edible vaccines. Curr Opin Biotechnol, 2000, 11: 126-129.
15. Polkinghorne I, Hamerli D, Cowan P, Duckworth J. Plant-based immunocontraceptive control of wildlife-"potentials, limitations, and possums". Vaccine, 2005, 23: 1847-1850.
16. Sala F, Rigano M M, Barbante A, Basso B, Walmsley A M, Castiglione S. Vaccine antigen production in transgenic plants: strategies, gene constructs and perspectives. Vaccine, 2003, 21: 803-808.
17. HUANG Zhong, Elkin Z, Maloney B J, Beuhner N, Arntzen C J, Thanavala Y, Mason H S. Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses. Vaccine, 2005, 23: 1851-1858.
18. Muller C P, Fack F, Damien B, Bouche F B. Immunogenic measles antigens expressed in plants: role as an edible vaccine for adults. Vaccine, 2003, 23: 816-819.
19. Koprowski H. Vaccines and sera through plant biotechnology. Vaccine, 2005, 23: 1757-1763.
20. Tacket C O, Mason H S. A review of oral vaccination with transgenic vegetables. Microbes Infect, 1999, 1(10): 777-783.
21. Mason H S, Warzecha H, Mor T, Arntzen C J. Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine. Trends Mol Med, 2002, 8(7): 324-329.
22. Trivedi P K, Nath P. MaExp1, an ethylene-induced expansin from ripening banana fruit. Plant Sci, 2004, 167: 1351-1358.
23. Carter J E, Langridge W H R. Plant-based vaccines for protection against infectious and autoimmune diseases. Crit Rev Plant Sci, 2002, 21: 93-109.
24. Sciutto E, Fragoso G, Manoutcharian K, Gevorkian G, Rosas-Salgad G, Hern á ndez-Gonzalez M, Herrera-Estrella L, Cabrera-Ponce J L, Lápez-Casillas F, González-Bonilla C, Santigago-Machuca A, Sanchez R J, Goldbaum F, Alujac A, Larraldea C. New approaches to improve peptide vaccine against porcine Taenia solium Cysticercosis. Arch Med Res, 2002, 33: 371-378.
25. Stoger E, Ma J K C, Fischer R, Christou P. Sowing the seeds of success: pharmaceutical proteins from plants. Curr Opin Biotechnol, 2005, 16: 167-173.
26. Streatfield S J, Lane J R, Brooks C A, Barker D K, Poage M L, Mayor J M, Lamphear B J, Drees C F, Jilka J M, Hood E E, Howard J A. Corn as a production system for human and animal vaccines. Vaccine, 2003, 21: 812-815.
27. Dus Santos M J, Wigdorovitz A, Trono K, R'ios R D, Franzone P M, Gil F, Moreno J, Carrillo C, Escribano J M, Borca M V. A novel methodology to develop a foot and mouth disease virus (FMDV) peptide-based vaccine in transgenic plants. Vaccine, 2002, 20: 1141-1147.
28. Hood E E. From green plants to industrial enzymes. Enzyme Microb Technol, 2002, 30: 279-283.
29. Hood E E, Woodard S L, Horn M E. Monoclonal antibody manufacturing in transgenic plants-myths and realities. Curr Opin Biotechnol, 2002, 13: 630-635.
30. Nicholson L, Gonzalez-Melendi P, van Dolleweerd C, Tuck H, Perrin Y, Ma J K C, Fischer R, Christou P, Stoger E. A recom-binant multimeric immunoglobulin expressed in rice shows assembly-dependent subcellular localization in endosperm cells. Plant Biotech J, 2003, 3: 115-127.
31. Mayfield S P, Franklin S E. Expression of human antibodies in eukaryotic micro-algae. Vaccine, 2005, 23: 1828-1832.
32. León-Bañares R, González-Ballester D, Galván A, Fernández E. Transgenic microalgae as green cell-factories. Trends Biotechnol, 2004, 22(1): 45-52.
33. SUN Meng, QIAN Kai-Xian, SU Ning, CHAN Hui-Yun, LIU Ji-Xing, SHEN Gui-Fang. Foot-and-mouth disease virus VP1 protein fused with cholera toxin B subunit expressed in Chlamydomonas reinhardtii chloroplast. Biotechnol Lett, 2003, 25: 1087-1092.
34. Zaslavskaia L A, Lippmeier J C, Kroth P G, Grossman A R, Apt K E. Transformation of the diatom phaeodactylum tricornutum. J Phycol, 2000, 36: 379-386.
35. Lohuis M R, Miller D J. Genetic transformation of dinoflagellates (Amphidinium and Symbiodinium): expression of GUS in microalgae using heterologous promoter constructs. Plant J, 1998, 13: 427-435.
36. Pryer K M, Schneider H, Zimmer E A, Banks J A. Deciding among green plants for whole genome studies. Trends Plant Sci, 2002, 7(12): 550-554.
37. Koprowski H, Yusibov V. The green revolution: plants as heterologous expression vectors. Vaccine, 2001, 19: 2735-2741.
38. Awram P, Gardner R C, Forster R L, Bellamy A R. The potemtial of plant viral vectors and transgenic plants for subunit vaccine production. Adv Virus Res, 2002, 58: 81-124.
39. Gleba Y, Klimyuk V, Marillonnet S. Magnifection - a new platform for expressing recombinant vaccines in plants. Vaccine, 2005, 23: 2042-2048.
40. Ma J K, Drake P M W, Christou P. The production of recombinant pharmaceutical proteins in plants. Nat Rev Genet, 2003, 4(10): 794-805.
41. Streatfield S J, Howard J A. Plant-based vaccines. Int J Parasitol, 2003, 33: 479-493.
42. Lamphear B J, Jilka J M, Kesl L, Welter M, Howard J A, Streatfield S J. A corn-based delivery system for animal vaccines: an oral transmissible gastroenteritis virus vaccine boosts lactogenic immunity in swine. Vaccine, 2004, 22: 2420-2424.
43. YU Jie, Langridge W H R. A plant-based multicomponent vaccine protects mice from enteric diseases. Nat Biotechnol, 2001, 19: 548-552.
44. WU Yu-Zhang, LI Jin-Tao, MOU Zhi-Rong, FEI Lei, NI Bing, GENG Miao, JIA Zheng-Cai, ZHOU Wei, ZOU Li-Yun, TANG Yan. Oral immunization with rotavirus VP7 expressed in transgenic potatoes induced high titers of mucosal neutralizing IgA. Virology, 2003, 313(2): 337-342.
45. Valdes R, Gomez L, Padilla S, Brito J, Reyes B, Alvarez T, Mendoza O, Herrera O, Ferro W, Pujol M, Leal V, Linares M, Hevia Y, Garcia C, Mila L, Garcia O, Sanchez R, Acosta A, Geada D, Paez R, Vega J L, Borroto C. Large-scale purification of an antibody directed against hepatitis B surface antigen from transgenic tobacco plants. Biochem Biophys Res Commun, 2003, 308: 94-100.
46. Chikwamba R K, Scott M P, Mejia L B, Mason H S, Wang K. Localization of a bacterial protein in starch granules of transgenic maize kernels. Proc Natl Acad Sci USA, 2003, 100: 11127-11132.
47. Tregoning J, Maliga P, Dougan G, Nixon P J. New advances in the production of edible plant vaccines: chloroplast expression of a tetanus vaccine antigen, TetC. Phytochemistry, 2004, 65: 989-994.
48. Lee J Y, Yu J, Henderson D, Langridge W H R. Plant-synthesized E. coli CFA/I fimbrial protein protects Caco-2 cells from bacterial attachment. Vaccine, 2004, 23: 222-231.
49. Kang Tae-Jin, Kang Kui-Hyeon, Kim Jin-Ah, Kwon Tae-Ho, Jang Yong-Suk, Yang Moon-Sik. High-level expression of the neutralizing epitope of porcine epidemic diarrhea virus by a tobacco mosaic virus-based vector. Protein Expres Purif, 2004, 38: 129-135.
50. Kim T G, Gruber A, Langridge W H R. HIV-1 gp120 V3 cholera toxin B subunit fusion gene expression in transgenic potato. Protein Expres Purif, 2004, 37: 196-202.
51. Ko K, Wei X, Crooks PA, Koprowski H. Elimination of alkaloids from plant-derived human monoclonal antibody. J Immunol Methods, 2004, 286: 79-85.
52. Maloney B J, Takeda N, Suzaki Y, Ami Y, LI Tian-Cheng, Miyamura T, Arntzen C J, Mason H S. Challenges in creating a vaccine to prevent hepatitis E. Vaccine, 2005, 23: 1870-1874.
53. Webster D E, Thomas M C, Huang Z, Wesselingh S L. The development of a plant-based vaccine for measles. Vaccine, 2005, 23: 1859-1865.
54. Karasev A V, Foulke S, Wellens C, Rich A, Shon K J, Zwierzynski I, Hone D, Koprowsi H, Reitz M. Plant based HIV-1 vaccine candidate: Tat protein produced in spinach. Vaccine, 2005, 23: 1875-1880.
55. DONG Jiang-Li, LIANG Ben-Guo, JIN Yong-Sheng, ZHANG Wan-Jun, WANG Tao. Oral immunization with pBsVP6-transgenic alfalfa protects mice against rotavirus infection. Virology, 2005, 339(2): 153-163.
56. Galeffi P, Lombardi A, Donato M Di, Latini A, Sperandei M, Cantale C, Giacomini P. Expression of single-chain antibodies in transgenic plants. Vaccine, 2005, 23: 1823-1827.
57. Yusibov V, Mett V, Mett V, Davidson C, Musiychuk K, Gilliam S, Farese A, Vittie T M, Mann D. Peptide-based candidate vaccine against respiratory syncytial virus. Vaccine, 2005, 23: 2261-2265.
58. Daniell H, Carmona-Sanchez O, Burns B. Chloroplast derived antibodies, biopharmaceuticals and edible vaccines. Molecular farming. Germany, Verlag Publishers, 2004, 113-133.
59. Daniell H, Chebolu S, Kumar S, Singleton M, Falconer R. Chloroplast-derived vaccine antigens and other therapeutic proteins. Vaccine, 2005, 23: 1779-1783.
60. Baez J, Russell D, Craig J. Corn seed production of therapeutic proteins moves forward, one company's experience. Biopharm, 2000, 13: 50-54.
61. Schillberg S, Twyman R M, Fischer R. Opportunities for recombinant antigen and antibody expression in transgenic plants-technology assessment. Vaccine, 2005, 23: 1764-1769.
62. Daniell H, Streatfield S J, Wycoff K. Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci, 2001, 6: 219-226.
63. Walmsley A M, Arntzen C J. Plant cell factories and mucosal vaccines. Curr Opin Biotechnol, 2003, 14: 145-150.
64. SU Tao, ZHAN Ya-Guang, HAN Mei, HAO Ai-Ping. Chloroplast genetic engineering: a new approach in plant biotechnology. Chinese J Biotecnol, 2005, 21(4): 674-680 (in Chinese with an English abstract).
65. ZHANG Chun-Xiao, WANG Wen-Qi, JIANG Xiang-Ning, CHEN Xue-Mei. Review on plant gene promoters. Acta Genetica Sinica, 2004, 31(12): 1455-1464 (in Chinese with an English abstract).
66. LI Yue-Qin, ZHU Jia-Ming, LI Hong-Jian, XIE Wei-Bing, ZHOU Tian-Hong, WANG Tong-Ge. The functin of T7 promoter as cis-acting elements for plolymerase II in eukaryotic cell. Acta Genetica Sinica, 2000, 27(5): 455-461 (in Chinese with an English abstract).
67. Bramwell V W, Eyles J E, Alpar H O. Particulate delivery systems for biodefense subunit vaccines. Adv Drug Deliver Rev, 2005, 57: 1247-1265.
68. ZHANG Geng-Lin, ZHOU Peng, GUO An-Ping, SHEN Wen-Tao, LI Xiao-Ying. An initial study of transgenic Carica papaya used as a kind of vaccine for anti-Tuberculosis. Acta Botanica Yunnanica, 2003, 25(2): 223-229 (in Chinese with an English abstract).
69. Conner A, Glare T, Nap J P. The release of genetically modified crops into the environment Part II: Overview of ecological risk assessment. Plant J, 2003, 33: 19-46.
70. Tripurani S K, Reddy N S, Sambasiva-Rao K R S. Green revolution vaccines, edible vaccines. African J of Biotechnol, 2003, 2(12): 679-683.
71. Mascia P N, Flavell R B. Safe and acceptable strategies for producing foreign molecules in plants. Curr Opin Plant Biol, 2004, 7: 189-195.
72. Warzecha H, Mason H S. Benefits and risks of antibody and vaccine production in transgenic plants. J Plant Physiol, 2003, 160(7): 755-764.
73. Daniell H, Khan M S, Allison L. Milestones in chloroplast genetic engineering: an environmental friendly era in biotechnology. Trends Plant Sci, 2002, 7: 84-91.
74. Peterson R K, Arntzen C J. On risk and plant-based biopharmaceuticals. Trends Biotechnol, 2004, 22: 64-66.
75. Maliga P. Engineering the plastid genome of higher plants. Curr Opin Plant Biol, 2002, 5: 164-172.
76. Yoshida K, Matsui T, Shinmyo A. The plant vesicular transport engineering for production of useful recombinant proteins. J Mol Catal B-Enzym, 2004, 28: 167-171.
77. Menessa R, Nguyen V, Jevnikar A, Brandle J. A self-contained system for the field production of plant recombinant interleukin-10. Mol Breed, 2001, 8: 177-185.